Mainolfi Nello sold KYMR
September 16, 2025 · Form 4 insider transaction
Mainolfi Nello sold 30,000 shares of Kymera Therapeutics, Inc. at $49.00 per share, a transaction worth $1.47M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
30,000
Price
$49.00
Total value
$1.47M
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2025
Filing dateSeptember 16, 2025
Shares owned after660,482
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.